maaf email atau password anda salah

Other Tempo Media
Majalah Tempo
Koran Tempo
Tempo.co
Subscribe

The AstraZeneca Controversy

Monday, March 22, 2021

The AstraZeneca vaccine came under the spotlight after several European countries postponed its use. In Indonesia, the vaccine’s halal status has become something of a controversy.

arsip tempo : 177092570597.

A medical worker fills a syringe with the AstraZeneca Covid-19 vaccine at a hospital in Tbilisi, Georgia, March 16. Reuters/Irakli Gedenidze . tempo : 177092570597.

INDONESIAN Ambassador for the United Arab Emirates, Husin Bagis, received the Covid-19 vaccination in October last year, the same with employees at the Indonesian embassy in Abu Dhabi. One month later, they received the second injection. “Everything went smoothly. The UAE government is among those pushing its Covid-19 vaccination program early,” Husin told Tempo via telephone on Friday, March 19.

Around 60 percent of the Emirates&rsq

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 750.000/12 months

  • *Flexible payment methods
  • *Unlimited access to Tempo Plus & Tempo Magz
Subscribe

Rp 386.280/6 months

  • *Auto-renews every 6 months
  • *Cancel at anytime
  • *Unlimited access to Tempo Plus & Tempo Magz
Subscribe

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

Gabriel Wahyu Titiyoga

AstraZeneca Vaccine
Prev Next

More Articles

More exclusive contents

  • February 9, 2026

  • February 2, 2026

  • January 26, 2026

  • January 19, 2026

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe